Nonproliferative Diabetic Retinopathy: Early Detection Matters
What Is Nonproliferative Diabetic Retinopathy?
NPDR develops when diabetes damages the tiny blood vessels in the retina, the light-sensitive layer at the back of the eye. These vessels begin to weaken and leak, causing changes that can gradually affect vision over time. Catching and managing NPDR early gives you the best chance of preventing serious vision loss.
When blood vessels in the retina are damaged by diabetes, they begin to leak blood, fluid, and cholesterol into the surrounding retinal tissue. Leaking blood causes small hemorrhages within the retina. Leaked fluid can cause the retina to swell, a condition called macular edema. Leaking cholesterol forms yellowish deposits known as hard exudates. These changes are often microscopic and invisible to the person experiencing them.
NPDR is distinguished from proliferative diabetic retinopathy (PDR), which is the more advanced form of the disease. In PDR, the retina becomes so oxygen-deprived that abnormal new blood vessels grow on its surface and into the vitreous, the gel-filled space inside the eye. These fragile vessels can bleed and lead to severe vision loss. In NPDR, this abnormal vessel growth has not yet occurred, making early identification and management critically important.
During a dilated eye examination, our specialists look for characteristic signs of NPDR. These findings help classify the severity of the disease and guide the next steps in your care.
- Microaneurysms: tiny bulges in weakened blood vessel walls
- Dot and blot hemorrhages: small spots of blood within the retina
- Hard exudates: yellowish deposits from leaking cholesterol
- Cotton-wool spots: pale patches caused by poor blood flow to small areas of the retina
NPDR is classified into mild, moderate, and severe stages based on the number and type of abnormalities present. Mild NPDR involves only a few microaneurysms. Moderate NPDR shows more widespread hemorrhages, microaneurysms, and possibly cotton-wool spots. Severe NPDR involves extensive hemorrhages and vascular abnormalities throughout the retina, and it carries a significantly higher risk of progressing to PDR within one year. Specialists use a standardized classification system called the Diabetic Retinopathy Severity Scale to monitor these stages over time.
Risk Factors and Who Is Affected
Diabetic retinopathy is one of the most common complications of diabetes, affecting a significant portion of people living with the condition. Several factors influence how quickly NPDR develops and how likely it is to progress. Understanding these factors helps you and your care team take meaningful steps to reduce your risk.
Diabetic retinopathy affects approximately one in four people with diabetes in the United States. It affects more people than age-related macular degeneration and glaucoma combined, making it a major public health concern and a condition our specialists take very seriously.
The longer a person has lived with diabetes, the greater the likelihood of developing retinal changes. Research has shown that NPDR was present in roughly one quarter of patients five years after a diabetes diagnosis, rising to about 60 percent at ten years and 80 percent at fifteen years. Consistently elevated blood sugar accelerates damage to retinal blood vessels, which means maintaining blood glucose levels as close to target as possible is one of the most effective ways to slow NPDR progression.
High blood pressure places additional stress on already weakened retinal vessels and is a major contributor to retinal damage in people with diabetes. Elevated triglyceride levels, a higher body mass index, and smoking are also linked to a greater risk of developing or worsening NPDR. Patients who have diabetic peripheral neuropathy, a form of nerve damage in the hands and feet, often have more advanced retinal changes as well, since these conditions share the same underlying vascular risk factors.
Both type 1 and type 2 diabetes can lead to diabetic retinopathy. Older adults are more likely to have lived with diabetes for a longer period, which increases cumulative risk. However, younger patients with type 1 diabetes can also develop significant retinal damage, particularly when blood sugar management has been challenging over time.
Signs and Symptoms
One of the most challenging aspects of NPDR is that it often causes no noticeable symptoms in its early stages. Many people with mild or moderate NPDR see normally and feel no discomfort. This makes routine eye exams essential for anyone with diabetes, because waiting for symptoms to appear before seeking evaluation can allow the disease to progress undetected.
The damage in NPDR happens inside the retina at a microscopic level, where it cannot be detected without specialized equipment. By the time a person notices changes in their vision, the disease may have already advanced to a more serious stage. Regular dilated eye exams are the only reliable way to detect NPDR before it causes lasting harm.
When NPDR does affect vision, it is usually because of diabetic macular edema (DME), which occurs when fluid leaks into the macula, the central part of the retina responsible for sharp detail vision. This can cause blurred or distorted central vision, difficulty reading, or trouble recognizing faces. Some patients notice that colors appear less vivid. These changes typically develop gradually rather than suddenly.
Certain symptoms may indicate that diabetic retinopathy has progressed to a more advanced or urgent stage. If you experience any of the following, seek evaluation right away or go to an emergency room without delay.
- A sudden increase in floaters (spots, strings, or shadows drifting across your vision)
- Flashes of light in one or both eyes
- A shadow, curtain, or dark area appearing over part of your visual field
- Sudden vision loss in one eye
How NPDR Is Diagnosed
Diagnosing NPDR requires a thorough eye examination combined with advanced imaging technology. Our specialists use several tests to evaluate the health of your retina, measure any swelling or fluid, and track changes over time. These evaluations are painless and typically completed during a single appointment.
The foundation of NPDR diagnosis is a comprehensive dilated eye exam. Eye drops are placed in the eyes to widen the pupils, giving our specialist a clear view of the retina. During this exam, the specialist looks for microaneurysms, hemorrhages, exudates, and cotton-wool spots that indicate early or advancing disease.
Optical coherence tomography, commonly called OCT, is a noninvasive imaging scan that produces detailed cross-sectional images of the retina. OCT can detect fluid within or beneath the retina, measure retinal thickness, and identify early macular edema before it affects vision. The scan is quick, painless, and provides critical information about the health of the macula.
Fluorescein angiography involves injecting a specialized dye into a vein in the arm. As the dye travels through the retinal blood vessels, a series of photographs is taken. These images reveal areas of leakage, reduced blood flow, and the distribution of microaneurysms. This test helps our specialist assess the severity of NPDR and identify areas at risk for further damage.
Ultra-widefield retinal photography captures detailed images of a large portion of the retina in a single photograph. These images are compared across visits to determine whether NPDR is stable or progressing. Retinal photography is a valuable tool for long-term monitoring, particularly in patients whose condition requires close follow-up.
Treatment Approaches for NPDR
Treatment for NPDR depends on the severity of the disease and whether macular edema is present. Many patients with mild to moderate NPDR are managed primarily through careful observation and systemic health control. When more active treatment is needed, several effective options are available.
For many patients with mild to moderate NPDR, the primary strategy is careful monitoring combined with tight control of diabetes, blood pressure, and cholesterol. This approach is supported by long-standing clinical research and remains the first-line recommendation for patients without macular edema or severe disease progression.
- Maintaining blood sugar levels as close to your target as your care team recommends
- Controlling blood pressure to reduce stress on retinal blood vessels
- Managing cholesterol and triglyceride levels
- Quitting smoking if applicable
- Maintaining a healthy weight through diet and physical activity
Anti-VEGF medications block a protein called vascular endothelial growth factor, which drives abnormal vessel growth and leakage in the eye. These medications are delivered as intravitreal injections, meaning they are injected directly into the eye using a very fine needle. Approved options include aflibercept, ranibizumab, bevacizumab (used off-label with well-documented results), and faricimab, which targets two pathways involved in retinal damage. Clinical trials have shown that anti-VEGF treatment can improve the measurable severity of NPDR and reduce the risk of vision-threatening complications in appropriate patients.
However, research has also shown that for patients with NPDR who do not yet have center-involved macular edema, early anti-VEGF treatment did not provide a long-term visual acuity benefit compared to careful observation. The decision to treat is individualized and based on disease severity, the presence of macular edema, and your overall health.
Scatter laser treatment, also called panretinal photocoagulation or PRP, uses targeted laser energy to treat oxygen-deprived areas of the retina. This approach is more commonly used in proliferative diabetic retinopathy but may be appropriate in selected cases of severe NPDR. Laser treatment does not restore lost vision but is designed to reduce the risk of further progression.
Fenofibrate is a medication commonly used to lower triglycerides. Research has suggested it may also help slow the progression of diabetic retinopathy, with the most notable benefit observed in patients with mild NPDR. A specialist or primary care physician can help you determine whether this medication is appropriate as part of your broader diabetes management plan.
Living With NPDR
A diagnosis of NPDR requires ongoing attention and proactive self-care, but it does not mean vision loss is inevitable. With the right management approach and regular follow-up, many people with NPDR maintain good vision for years. Understanding what to expect and how to stay on top of your care makes a meaningful difference in long-term outcomes.
The frequency of follow-up appointments depends on the severity of your NPDR. Mild NPDR typically calls for exams every six to twelve months. Moderate NPDR usually requires visits every three to six months. Severe NPDR may need follow-up every two to four months due to the elevated risk of progression to PDR. Your schedule may be adjusted based on how your condition responds to management and what new findings appear on imaging.
At each visit, our specialist will perform a dilated exam and typically obtain OCT imaging to assess the macula. You may be asked about any changes in your vision, recent blood sugar readings, and any updates to your medications. These visits are designed to catch changes early so that treatment can be started promptly if needed.
Keeping blood sugar, blood pressure, and cholesterol well controlled are the most impactful steps you can take to protect your vision. Working closely with your primary care physician or endocrinologist is essential. Even modest improvements in these areas can slow or halt the progression of NPDR over time.
Regular physical activity, a balanced diet, not smoking, and maintaining a healthy weight all support better blood vessel health throughout the body, including the retina. It is also natural to feel concern after a diagnosis that involves your eyesight. It may help to know that mild to moderate NPDR often remains stable for years with proper management, and many people with NPDR maintain good vision throughout their lives. Staying informed and attending all scheduled appointments are among the most empowering things you can do.
When to See a Specialist
Timely evaluation is one of the most effective tools in preventing vision loss from diabetic retinopathy. Whether you are newly diagnosed with diabetes or have been managing it for years, knowing when to seek care, and when to seek it urgently, is essential knowledge for every patient.
All people with diabetes should have a comprehensive dilated eye exam at least once a year. Screening should begin within five years of a type 1 diabetes diagnosis and at the time of a type 2 diabetes diagnosis. Pregnant individuals with diabetes should have an eye exam during the first trimester, as pregnancy can affect the course of diabetic retinopathy.
Beyond routine screenings, contact our office promptly if you notice blurred or distorted central vision, difficulty reading, or a change in color perception. Any sudden increase in floaters, flashes of light, a shadow or curtain over your visual field, or sudden vision loss in one eye requires immediate care. Go to an emergency room or contact our office right away, as these may indicate that diabetic retinopathy has progressed to a serious or sight-threatening stage.
Frequently Asked Questions
These answers address common questions that go beyond what is covered in the sections above, offering additional guidance to help you make informed decisions about your eye care.
Clinical trials have shown that anti-VEGF treatment can improve the measurable severity score of NPDR, meaning that the visible signs of retinal damage can be reduced. However, this is not the same as a complete reversal of all underlying structural damage to the retina. Improvement in severity scores is most likely in patients who receive treatment while in the moderate to severe stage. The most reliable long-term strategy remains tight control of blood sugar, blood pressure, and other systemic risk factors.
Not every patient with NPDR requires injections. Many people with mild to moderate NPDR are successfully managed through close monitoring and systemic health control alone. Injections are most commonly recommended when diabetic macular edema develops or when NPDR is classified as severe. Research has also shown that for patients with NPDR who do not yet have macular edema affecting the center of vision, early injection treatment did not offer a lasting improvement in visual clarity over observation. Your specialist will tailor the recommendation to your specific situation.
Progression varies considerably depending on the severity of NPDR and how well risk factors are managed. Patients with mild NPDR who maintain strong blood sugar and blood pressure control may remain stable for many years without advancing. Patients with severe NPDR, on the other hand, face a meaningfully higher risk of progressing to PDR within one year. This is why the stage of your NPDR matters so much when planning your monitoring schedule and discussing treatment options.
A diagnosis of NPDR does not mean that you will lose your vision. Many people with mild or moderate NPDR maintain good vision for years or even decades, particularly when diabetes is well managed. Serious vision loss from diabetic retinopathy is most commonly associated with untreated macular edema or progression to advanced proliferative disease. Regular monitoring and proactive care significantly reduce the risk of reaching that stage.
There is currently no strong clinical evidence that any over-the-counter supplement can reliably prevent or treat diabetic retinopathy. Some research has explored antioxidants and omega-3 fatty acids, but results have not been conclusive enough to support a specific recommendation. Rather than relying on supplements, the most effective approaches remain blood sugar control, blood pressure management, lifestyle modification, and regular evaluation by a specialist.
Do not wait until your next scheduled exam if you notice a meaningful change in your vision. Even gradual changes such as increased blurriness, difficulty reading, or new distortion in your central vision deserve prompt attention. Sudden changes involving floaters, flashes, shadows, or loss of vision should be treated as urgent, and you should seek care the same day. Early intervention at any stage of retinal disease almost always leads to better outcomes than delayed treatment.
See Our Specialists at Associated Eye Physicians & Surgeons
If you have diabetes and have not had a recent dilated eye exam, we encourage you to schedule an appointment with our team. Associated Eye Physicians & Surgeons offers comprehensive diabetic eye care across our convenient locations throughout New Jersey, with the advanced technology and personalized attention your eyes deserve. Our specialists are committed to detecting retinal changes early and partnering with you to protect your vision at every stage of care.
If you need an ophthalmologist, go here. The doctors and the office personnel are kind, caring and most importantly, highly competent!!
Don
Excellent attentive service provided expeditiously! True professionals to deal with give you the feeling of total confidence in their ability to help you!
michael scalzo
Prompt, skilled, courteous, and excellent service in a well established office.
Anthony Posteraro
Helpful and friendly receptionist and technicians. Great doctor and excellent care.
Deborah W
I wanted to express my deepest gratitude for the remarkable care and expertise Dr. Garrana provided during my PRK surgery with cross-linking. Her skills and dedication have truly changed my life in ways I never thought possible. Thanks to the exceptional treatment, my vision has been transformed.
Ramzi C.